Level 2: School

ESMIT Spring School 2018

May 4-6, 2018
Campus De Sterre
Ghent, Belgium

An application has been made to UEMS-EACCME for CME accreditation of this event

icon_question_pur How to travel to Ghent

Exact Address: Campus De Sterre, Krijgslaan 281, 9000 Ghent

Flights to Brussels followed by a train ride to Ghent. Details such as timetables, available tickets and prices can be found on following websites:

Brussels Airport      Train Connections

Find hereunder a helpful homepage where you can find the best travel route from your hometown to Ghent (or any other destination):


icon_question_pur How to register

Each track will allow a maximum of 40 participants. Registrations will be accepted on a first come first serve basis, however, EANM members will be given relative priority.

Online Registration (registration deadline extended to April 13, 2018)

If online registration is not possible, please contact us: esmit@eanm.org

icon_ticket_pur Registration fees

Flat rate € 250.- for 2 Tracks

Registration fee includes:

  • Electronic course programme book including all slides
  • Coffee & Lunch breaks on each School day

Registration fee does NOT include:

  • Travel to the venue
  • Accommodation

icon_payment_pur Mode of payment

Registration fees need to be paid 4 weeks prior to the event. In case the payment is not received by this deadline, the registration needs to be cancelled. Payment can be settled by

  • credit card
  • bank transfer to:
    Bank name: Die ERSTE Bank
    Banking Code: 20111
    Account number: 28120039900
    IBAN Code: AT602011128120039900
  • Cheques will NOT be accepted.

icon_cancellation_pur Cancellation policy

Cancellations must be notified in writing to the ESMIT Office. Telephone cancellations cannot be accepted. Substitutions will be accepted and can be made at any time. Name and e-mail address of substitutes need to be sent to the EANM office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course, we will refund you the fee less a € 100,- administration charge.
After this date we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels, airlines or other means of transportation.

Oncology Track
Multimodality Imaging in Gynaecological Malignancies

This track has been designed so that the attendees will learn the key aspects of MM imaging for the diagnosis, staging, prognostic evaluation and treatment assessment of gynaecological malignancies.

During the track attendees will listen refresher theoretical lectures from our experienced speakers on the most relevant imaging and clinical aspects of gynaecological malignancies. The track will start with lectures presenting the principal radiological characteristics of these malignancies, followed by a comprehensive overview of the most common imaging procedures used in diagnosis and treatment assessment and discussions of the current guidelines.

Cross sectional anatomy will be accompanied with case studies, focusing on the clinical difficulties encountered in the daily practice most frequently. Critical pitfalls of each imaging procedure will be reviewed as well as the main weakness and strength of each diagnostic modality in relation to cancer type, stage of the disease and previous treatment.

A clinical Onco-gynaecologist will give an overview of current treatment options and discuss treatment concepts fundamental for proper imaging reading in the setting of treatment evaluation. 

Interaction among instructors and attendees is guaranteed via practical questions during lectures and interactive cases presentation with a dedicated software platform. Furthermore, case studies in small groups with the use of state of the art workstations will be available for all participants, to solidify the gained knowledge with hands on analysis of clinical cases. 

Target audience

We recommend this track to all imaging specialist interested in the field of oncology to improve their confidence in reading MM images in a hybrid approach and prepare themselves for the clinical discussion with the referring clinician in a multidisciplinary board. Also, clinicians working in this area interested in improving their understanding for multimodality imaging would greatly benefit from this educational event.

Educational Objectives

  • To learn the adequate use of the most relevant MM imaging tools for the diagnosis, staging, prognostic evaluation and treatment assessment of Gynaecological malignancies
  • To improve the interpretation skills in these scenarios
  • To identify potential pitfalls during imaging
  • To know the current treatment options


Dr. Irene Burger
Dr. Teresa Margarida Cunha

 icon_suggestedreadings_pur Suggested Readings:

Online material covering topics that might be of help for a better understanding of the Level 2 Onco Track
Introduction to MR-Based AC (EANM’17 CME 1, Lecture 1)
MR Based Attenuation Correction for the Body (EANM’17 CME 1, Lecture 3)
Breast and Gynecological Tumours (EANM’16 CME 3, Lecture 2)
Simultaneous PET-MR: Strengths and Weaknesses from Instrumentation to Applications (EANM’16 CME 9, Lecture 3)
New ESGO-ESTRO-ESP Cervical Cancer Clinical Management Guidelines 2017 (ESO Oncology e-learning)
New classification of gynaecologic cancers (ESO Oncology e-learning)
Gynaecological Cancer: Cervical and endometrial cancers (ESO Oncology e-learning)
Ovarian cancer (ESO Oncology e-learning)
Molecular pathology in ovarian cancer (ESO Oncology e-learning)
National Comprehensive Cancer Network (NCCN)
eAcademy of the European Society of Gynaecological Oncology (ESGO)
Module on Ovarian Cancer provided by the U.S. National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) Program

icon_ruuicula_pur The Role of PET/CT in the Management of Cervical Cancer; Sahar Mirpour, Joyce C. Mhlanga, Prashanti Logeswaran, Gregory Russo, Gustavo Mercier, and Rathan M. Subramaniam; American Journal of Roentgenology 2013 201:2W192-W205
icon_ruuicula_pur PET/CT and MRI in the imaging assessment of cervical cancer; Joanna Kusmirek, Jessica Robbins, Hailey Allen,Lisa Barroilhet, Bethany Anderson, Elizabeth A. Sadowski; Abdominal Imaging, October 2015, Volume 40, Issue 7, pp 2486–2511|
icon_ruuicula_pur MRI of ovarian masses; Vargas HA, Barrett T, Sala E.; J Magn Reson Imaging. 2013 Feb;37(2):265-81. doi: 10.1002/jmri.23721
icon_ruuicula_pur Pearls and Pitfalls in MRI of Gynecologic Malignancy With Diffusion-Weighted Technique; Stephanie Nougaret, Sree Harsha Tirumani, Helen Addley, Himanshu Pandey, Evis Sala, and Caroline Reinhold; American Journal of Roentgenology 2013 200:2, 261-276
icon_ruuicula_pur PET/MR imaging of pelvic malignancies; Axel Wetter, Johannes Grueneisen, Lale Umutlu; European Journal of Radiology , Volume 94 , A44 – A51

 icon_ruuicula_pur  Curricula Oncology Track

The School consists of 4 parallel tracks held during 3 consecutive days. Each track takes 1,5 days and all tracks start over again, which allows each participant to attend 2 tracks in a row.

download Curriculum of Oncology Track 1

download Curriculum of Oncology Track 2

Neurology Track
Brain tumour & Epilepsy

The Neurology Track (Neuro) will offer a comprehensive overview of basic, theoretical and practical evidence-based concepts needed for a deeper and thoughtful understanding of the use of molecular imaging in neurology and neurooncology. As design in all new level 2 courses short theoretical sessions will be associated with longer hands-on sessions, for a practice-oriented learning. After a short refresh on radiopharmaceutical and image analysis, the role of molecular imaging in both epilepsy and neoplastic brain diseases will be discussed. Clinical cases will be the starting point to better define the usefulness, utility and accurate reading of PET and SPECT in Epilepsy and Brain Tumors. Specific attention will be dedicated to the definition of diagnostic algorithms in these neurological disorders (taking into account the added value of both molecular and structural/conventional imaging methods and most of all of hybrid scanners).

Target audience

Level 2 Neuro track is aimed to resident, and general nuclear medicine specialists, radiologists who want to update their knowledge on state-of-the-art multimodal neuroimaging in terms of clinical indications, reading skills and pitfalls. The emerging role of Brain PET and SPECT in epilepsy and brain tumor makes the track of interest for neurologists who want to improve their knowledge of cutting-edge Neuroimaging tools.

Educational Objectives

  • To understand clinical indications and diagnostic algorithms of brain PET, SPECT and MRI in Epilepsy and Brain Tumors
  • To improve attendees skills on reading and reporting of brain PET and SPECT in epilepsy and brain tumors
  • To understand and compare the added and different value of the available PET and SPECT tracers with respect to structural imaging in epilepsy and brain tumors.


Prof. Dr. Javier Arbizu
Prof. Franck Semah

 icon_suggestedreadings_pur Suggested Readings:

Online material covering topics that might be of help for a better understanding of the Level 2 Neuro Track

 PET/CT for Technologists Webinar Series
 Basic PET physics and instrumentation – part 1 (Basic NM Webinar)
 Basic PET physics and instrumentation – part 2 (Basic NM Webinar)
 Introduction to Nuclear Medicine in Neurology: bases for clinical us (Basic NM Webinar)
 Brain tumor imaging (Basic NM Webinar)
 New Insights in Molecular Neuroimaging (Plenary session 3 – EANM’ 13)
 Brain PET Imaging (CME 9 session – EANM’ 13)
 Cross-sectional Imaging in Nuclear Medicine (CME 12 session – EANM’ 13)
Module on Brain & other nervous system tumors provided by the U.S. National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) Program
icon_globe Clinical and radiological background on brain tumors
icon_globe Anatomy: Free brain atlas of Mri and PET
icon_globe Online tutorials for Nuclear Medicine and Radiology Technologists as well as students (NucmedTutorials)
icon_globe Case based learning in scintigraphic imaging techniques, using hybrid imaging modalities like PET-CT and SPECT-CT (NuclearMD)
icon_globe PET-CT Cases (NuclearMD)
icon_globe Other Online Resources (NuclearMD)
icon_globe Forum for radiologists and related professionals in the medical imaging industry (AuntMinnie)
icon_globe Website dedicated to radiology (W-Radiology)

  • Koepp MJ and Woermann FG. Imaging structure and function in refractory epilepsy. Lancet Neurol 2005; 4: 42-53
  • Goffin K et al. Neuronuclear assessment of patients with epilepsy. Semin Nucl Med 2008; 38:227-239.
  • Desai A et al. Interictal PET and ictal subtraction SPECT: Sensitivity in the detection of seizure foci in patients with medically intractable epilepsy. Epilepsia 2013;54:341–350.
  • Kumar A, Chugani HT. The Role of Radionuclide Imaging in Epilepsy, Part 1: Sporadic Temporal and Extratemporal Lobe Epilepsy. J Nucl Med 2013; 54:1775–1781.
  • Kumar A, Chugani HT. The Role of Radionuclide Imaging in Epilepsy, Part 2: Epilepsy Syndromes. J Nucl Med 2013; 54:1924–1930.Varrone A et al EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2. Eur J Nucl Med Mol Imaging. 2009 Dec;36(12):2103-10
  • Herholz K, Langen KJ, Schiepers C, Mountz JM. Brain tumors. Semin Nucl Med. 2012 Nov;42(6):356-70.
  • Herholz K.  Brain Tumors: An Update on Clinical PET Research in Gliomas. Semin Nucl Med. 2017 Jan;47(1):5-17.
  • Albert NL et al Response Assessment in Neuro-Oncology working group and European Association for  Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. Neuro Oncol. 2016 Sep;18(9):1199-208
  • Galldiks N et al The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy. Neuroimage Clin. 2016 Dec 18;13:386-394
  • Soffietti R et al Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO). Neuro Oncol. 2017 Feb 1;19(2):162-174
  • Ladefoged CN et al A multi-centre evaluation of eleven clinically feasible brain PET/MRI attenuation correction techniques using a large cohort of patients. Neuroimage. 2017 Feb 15;147:346-359. doi: 10.1016/j.neuroimage.2016.12.010.

 icon_ruuicula_pur  Curricula Neurology Track

The School consists of 4 parallel tracks held during 3 consecutive days. Each track takes 1,5 days and all tracks start over again, which allows each participant to attend 2 tracks in a row.

download Curriculum of Neurology Track 1

download Curriculum of Neurology Track 2

1st Paediatric Oncologic Track
Overview with Special Focus on Hodgkin Lymphoma

This is the first course of a series focussing on paediatric oncology and multimodal imaging.

The first two sessions of this course are intended to present an overview of the most common paediatric cancer types and to repeat, extend and deepen the knowledge gained from ESMIT Course Level I. The new studying technique being applied during these two sessions will be a group puzzle so that everyone will be actively involved.

Session III will focus on pitfalls and artifacts that can occur in nuclear medicine imaging techniques when performed in children and adolescents. This session will especially underline the importance of multimodality imaging.

In the 4th session different imaging protocols (including different tracers) will be introduced and discussed.

A special focus is thereby put on patient preparation which is crucial, especially in children.

Sessions V to VIII will provide special and profound knowledge on Hodgkin Lymphoma. Since paediatric cancer types are relatively rare we found it useful to demonstrate – based on the EuroNet study group – how multicentre trials can be organized and how important it is to work together in order to gain enough and sufficient data to reliably answer clinical questions. The other sessions are organized to cover initial staging and response assessment as well as future applications of F18-FDG-PET in Hodgkin Lymphoma.

All eight sessions are a potpourri of lectures, interesting interactive case-readings and hands-on sessions.

Each upcoming ESMIT 2 course on paediatric oncology will be organized to cover two other cancer types, e. g. neuroblastoma and brain tumours (2019) OR sarcoma and thyroid cancer (2020). After that series update courses are planned.


Educational Objectives

Each participant will gain and consolidate basic knowledge on the most common paediatric cancer types (lymphoma, neuroblastoma, sarcoma, thyroid cancer and brain tumours) and the most common imaging protocols with tips for patient preparation. In addition, profound expert knowledge will be provided on Hodgkin Lymphoma.

Target Audience

  • Medical specialists and physicians in-training (residents) with special interest in paediatric nuclear medicine and paediatric multimodality imaging


Dr. Lars Kurch
Prof. Regine Kluge
Dr. Arnoldo Piccardo

 icon_suggestedreadings_pur Suggested Readings:

Online material covering topics that might be of help for a better understanding of the Level 2 Paediatric Track

  • Webinars

ESMIT/IAEA Webinar on PET/CT in paediatric lymphoma
ESMIT/IAEA Webinar on Multimodality Imaging in Paediatric Oncology
ESMIT/IAEA Webinar on Paediatric Neuroblastoma Imaging
ESMIT/IAEA Webinar on Brain tumors in paediatrics

Pitfalls & Artefacts Track Session 4 – EANM’17: Paediatrics: Pitfalls and Artefacts – FDG-PET Imaging in Children (Lecture 1: Patient preparation and Technical Artefacts & Lecture 2: Clinical Pitfalls)
CME 9 Session – EANM’17: Paediatrics/Inflammation & Infection: FDG PET in Paediatric Infections (Lecture 1: FDG PET in the Evaluation of Lymphadenopathy in Children)
CME 11 Session – EANM’17: Paediatrics/Oncology/SIOPEN: SSR Imaging and Therapy in Children (Lecture 1: The Importance of miBG in the International Neuroblastoma Community. Perspectives from SIOPEN Collab; Lecture 2: Somatostatin Receptor Imaging in Paediatric Tumours)
CME 1 Session – EANM’16: Paediatrics/Oncology/ELI: PET in Lymphoma: What are the New Fields in Adult and Paediatric Practice? (all three lectures)
CME 10 Session – EANM’14: Paediatrics & Oncology: Therapy Response Monitoring in Paediatric Oncology (all three lectures)


  • Vini L et al: Prognosis for fertility and ovarian function after treatment with radioiodine for thyroid cancer, Postgraduate Medical Journal. 2002;78:92-93
  • Francis GL et al: Management guidelines for children with thyroid nodules and differentiated thyroid cancer, Thyroid. 2015;25:716-759
  • Handkiewicz-Junak D et al: Recombinant human thyrotropin preparation for adjuvant radioiodine treatment in children and adolescents with differentiated thyroid cancer, European Journal of Endocrinology. 2015;173:873-881
  • Padma s et al: PET/CT in paediatric malignancies – An update, Indian Journal of Medical and Paediatric Oncology. 2016;37:131-140
  • Kiratli P Ö et al: Nuclear Medicine in Pediatric and Adolescents Tumors, Seminars in Nuclear Medicine. 2016;46:308-323
  • Harrison JD et al: The role of F18-FDG-PET/CT in Pediatric Sarcoma, Seminars in Nuclear Medicine. 2017;47:229-241
  • Pfluger T et al: Neuroblastoma: MIBG Imaging and New Tracers, Seminars in Nuclear Medicine. 2017;47:143-157
  • Kluge R et al: Current role of FDG-PET in Pediatric Hodgkin’s Lymphoma, Seminars in Nuclear Medicine. 2017;47:242-257


  • Mansi L et al: Clinical Nuclear Medicine in Pediatrics, ISBN: 978-3-319-21370-5

 icon_ruuicula_pur  Curricula Paediatric Track

The School consists of 4 parallel tracks held during 3 consecutive days. Each track takes 1,5 days and all tracks start over again, which allows each participant to attend 2 tracks in a row.

download Curriculum of Paediatric Track 1

download Curriculum of Paediatric Track 2

Theranostics Track
Theranostics – clinical and non-clinical aspects (radiopharmacy, physics and dosimetry) of NENs

This track has been designed having in mind two main aims. First, the attendees will learn about the clinical aspects of molecular imaging and peptide receptor radionuclide therapy of NEN patient. Second, this is the first track that offers also insight into the non-clinical topics related to NEN patient management.

After introductory refresher in the concept of theranostics and its relevance in NEN, the non-clinical part will follow, focused on radiopharmaceuticals, physics and dosimetry connected to the NEN. The attendees will learn about different possibilities regarding radionuclide and radiopharmaceutical selection, production and consideration regarding regulations in relation to premises, equipment and personnel. After interactive part on selecting of the most suitable radiopharmaceutical for the individual patient, refresher on image quantification and image fusion intertwined with interactive case reading will follow. During a dosimetry slot the attendees will learn how to calculate a tumour and/or a kidney absorbed dose and how to tailor the individual patient dose for PRRT accordingly.

In clinical part of this track the attendees will learn about SPECT/CT and PET/CT imaging in establishing diagnosis, staging, restaging and therapy response of NENs. The value of CT and MRI in conjunction with functional imaging will be discussed. Additionally, the clinical value of SST receptor specific vs. metabolic imaging and its individual relevance as diagnostic and/or prognostic tool, their role in staging, predicting response to PRRT and in assessing tumour dedifferentiation will be discussed.

Tumour Board with discussion of clinical cases will wrap up the track.

We believe that combining knowledge of clinical with non-clinical aspect of theranostics in NEN patients will result in synergetic output, enabling improved understanding and management of demanding interdisciplinary team-work.


Target Audience

We recommend this track to all imaging specialist interested or working in the field of NEN patient management, imaging and therapy. Also, clinicians working in this area could greatly benefit from this topic.


Cecilia Hindorf (Physics)
Petra Kolenc Peitl (Radiopharmacy)
Rudolf Alexander Hermann Werner (Oncology)
Klaus Bacher (Dosimetry)

 icon_suggestedreadings_pur Suggested Readings:

Online material covering topics that might be of help for a better understanding of the Level 2 Theranostics Track

Webinar Series on Present and Future of NET Management
Webinar Series on Basic Nuclear Medicine
PET/CT for Planning and Monitoring of Targeted Radiotherapy
PET/CT Peptide imaging
Optimisation of image acquisition and re-construction with PET/CT
Quality management of PET/CT systems – international standards

 icon_ruuicula_pur  Curricula Theranostics Track

The School consists of 4 parallel tracks held during 3 consecutive days. Each track takes 1,5 days and all tracks start over again, which allows each participant to attend 2 tracks in a row.

download Curriculum of Theranostics Track 1

download Curriculum of Theranostics Track 2

Back to top